跳至主要内容
临床试验/CTIS2023-503912-34-00
CTIS2023-503912-34-00招募中1 期

NAC for reversal of opioid-induced respiratory depression

eiden University Medical Center0 个研究点目标入组 18 人开始时间: 2023年3月10日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • Age 18-40 years, Body Mass Index 19-30 kg/m2, Able to read and understand the subject information

排除标准

  • A medical history of medical or psychiatric disease, any allergy to food or medication, weekly ethanol intake of more than 3 units/day or more than 21 units/week in women and 5 units/day and 35 units/week in men, pregnancy or lactation, women of childbearing potential (defined as all women who are not surgically sterile or postmenopausal for at least 1 year prior to informed consent) must have a negative urine pregnancy test prior to enrolment and must agree to use a medically acceptable means of contraception from screening through at least 1 month after the last dose of study drug, participation in an investigational drug trial in the 3 months before the current study, illicit drug use in the 30 days before the current study, a positive drug urine dipstick on the screening or study days

研究者

发起方
eiden University Medical Center

相似试验